» Articles » PMID: 17295053

Attitudes Toward Fragile X Mutation Carrier Testing from Women Identified in a General Population Survey

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2007 Feb 14
PMID 17295053
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Fragile X syndrome is primarily due to a CGG repeat expansion found in the FMR1 X-linked gene. In a previous study, we conducted focus groups with women to assess their attitudes towards fragile X carrier screening. In this follow-up study, we conducted in-depth interviews of general population reproductive-age women who were identified as carriers. We explored their attitudes toward testing for carrier status of the fragile X mutation. These women underwent screening primarily to participate in a research project rather than in search of a diagnosis for specific symptoms. As such, these women were wholly unprepared for positive carrier results. Their responses about their results and carrier screening, in many cases, were being worked out over the course of the interview itself. The most salient finding of this work is the apparent lack of relevance of carrier status to these women. Many expressed that although the information could be relevant in the future, it is not relevant at this stage of their lives in terms of family planning (either with respect to having unaffected offspring or to premature ovarian failure) and personal relationships. Although issues of abortion seemed prominent in the focus groups, we found that carrier status did not have an apparent effect on women's attitudes about termination. We hypothesize this may be related to the fact that women had not processed their new carrier status and had not related it to previously-formed personal opinions. The findings of this work have significant implications for genetic counseling and population screening. Genetic counselors should be mindful that general population women may not recognize the immediate importance of their carrier status even when literature is provided and discussed prior to providing a sample. As part of comprehensive genetic counseling, counselors should identify the reproductive life stage of the woman receiving the new information and help her identify when this information would be more meaningful in her life. Counselors can assist in setting up a personalized road map with specific types of services that will be more applicable to the woman as her carrier status becomes more relevant.

Citing Articles

Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size.

Allen E, Charen K, Hipp H, Shubeck L, Amin A, He W Genet Med. 2021; 23(9):1648-1655.

PMID: 33927378 PMC: 8460441. DOI: 10.1038/s41436-021-01177-y.


Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.

Boardman F J Genet Couns. 2020; 30(1):85-97.

PMID: 33184995 PMC: 7894324. DOI: 10.1002/jgc4.1355.


Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals.

Budimirovic D, Cvjetkovic S, Bukumiric Z, Duy P, Protic D Front Neurosci. 2018; 12:652.

PMID: 30297982 PMC: 6160902. DOI: 10.3389/fnins.2018.00652.


Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.

Mathijssen I, Holtkamp K, Ottenheim C, van Eeten-Nijman J, Lakeman P, Meijers-Heijboer H Eur J Hum Genet. 2018; 26(2):166-175.

PMID: 29321671 PMC: 5838981. DOI: 10.1038/s41431-017-0056-4.


Family Communication and Cascade Testing for Fragile X Syndrome.

Raspa M, Edwards A, Wheeler A, Bishop E, Bailey Jr D J Genet Couns. 2016; 25(5):1075-84.

PMID: 26961978 DOI: 10.1007/s10897-016-9940-2.


References
1.
Bailey Jr D . Newborn screening for fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004; 10(1):3-10. DOI: 10.1002/mrdd.20002. View

2.
Henneman L, Bramsen I, van Os T, Reuling I, Heyerman H, van der Laag J . Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenat Diagn. 2001; 21(1):1-9. DOI: 10.1002/1097-0223(200101)21:1<1::aid-pd967>3.0.co;2-#. View

3.
McConkie-Rosell A, Spiridigliozzi G, Sullivan J, Dawson D, Lachiewicz A . Carrier testing in fragile X syndrome: effect on self-concept. Am J Med Genet. 2000; 92(5):336-42. DOI: 10.1002/1096-8628(20000619)92:5<336::aid-ajmg8>3.0.co;2-l. View

4.
Clayton E, Hannig V, Pfotenhauer J, Parker R, Campbell 3rd P, Phillips 3rd J . Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet. 1996; 58(3):617-27. PMC: 1914565. View

5.
Mennie M, Compton M, Gilfillan A, Liston W, Pullen I, Whyte D . Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet. 1993; 30(7):543-8. PMC: 1016452. DOI: 10.1136/jmg.30.7.543. View